The requirement to obtain the consent of a legal guardian for the provision of reproductive health pharmacist services to minors under the pilot program

Authors

  • Marek Tomków Department of Pharmacy and Ecological Chemistry, Faculty of Chemistry, University of Opole, Poland Author
  • Radosław Jerzy Balwierz Department of Pharmacy and Ecological Chemistry, Faculty of Chemistry, University of Opole, Poland Author
  • Adam Majewski Laboratory of Medical and Pharmaceutical Law, Faculty of Medical Sciences, Medical University of Lublin, Poland Author
  • Aleksandra Szopa Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Lublin, Poland Author

DOI:

https://doi.org/10.12923/2083-4829/2024-0014

Keywords:

emergency contraception, pharmacist service, pharmaceutical service, legislation, morning-after pill

Abstract

Emergency contraception in Poland is often referred to as the “morning-after pill”. Its legal status has changed many times. In Poland, it has only been available on prescription since 2017. Attempts have been made to change the legal status in 2024. A draft amendment to the Pharmaceutical Act was then submitted to Parliament. However, the bill was vetoed by the President of the Republic of Poland. In response to the veto, the Minister of Health issued a decree on a pilot programme in the field of pharmacists’ services related to reproductive health. In connection with this regulation, a question arose for pharmacists: whether it is necessary to obtain the consent of the legal guardian of minors who want to use the programme. Therefore, the aim of the work was a legal-comparative and dogmatic-legal analysis of legal acts in the field of reproductive health. A review of the data shows that while the pharmacist carries out the activities indicated in the pilot programme for pharmacist services about reproductive health, health services are provided to patients. Therefore, in the case of minor patients under 16 years of age, or who are over 16 but under 18 years of age, the consent of their legal representatives is required. It should also be noted that the term “pharmacist service” used in the title is not defined in any way in the law (unlike the term “pharmaceutical service”) and does not constitute a definition that would allow the statement to be made that it is another unlisted activity that exempts the pharmacist from the obligation to obtain the consent of the legal guardian. It should therefore be assumed that this consent is necessary to provide the service.

References

1. The Pex company data from 13 June 2024.

2. Family Planning. A global handbook for providers, 2022 edition. [https://www.who.int/publications/i/item/9780999203705] (access: 25.06.2024).

3. Commission Implementing Decision of 7.01.2015 on the modification of the marketing authorisation of the medicinal product for human use ‘ellaOne – ulipristal acetate’ granted by Decision K (2009)4049.

4. Regulation of the Minister of Health of 2 April 2015 amending the Regulation on the dispensing of medicinal products and medical devices from a pharmacy. Journal of Laws 2015, item 477.

5. Emergency contraception. Ministry of Health. [https://www.gov.pl/web/zdrowie/antykoncepcja-awaryjna] (access: 25.06.2024).

6. Act of 25 May 2017 amending the Act on health care services financed from public funds and certain other acts. Journal of Laws 2017, item 1200.

7. Art. 23a sec. 2 of the Law of 6 September 2001. Pharmaceutical Law (consolidated text: Journal of Laws of 2024, item 686.

8. Draft Act – amending the Pharmaceutical Act of 29 January 2024. [https://orka.sejm.gov.pl/Druki10ka.nsf/0/9E7BB07DF277AC1DC1258AB600501732/$File/185.pdf.] (access: 25.06.2024).

9. Regulation of the Minister of Health of 29 April 2024 on the pilot programme of pharmacist services related to reproductive health. Journal of Laws of 2024, item 662.

10. §5 sec.2 of the Regulation of the Minister of Health of 29 April 2024 on the pilot programme of pharmacist services in the field of reproductive health. Journal of Laws of 2024, item 662).

11. Szczepańska A. Leszczyna: pigułka „dzień po” przed osiemnastką bez zgody rodziców. [https://cowzdrowiu.pl/aktualnosci/post/leszczyna-pigulka-dzien-po-przed-osiemnastka-bez-zgody-rodzicow] (access: 25.06.2024).

12. Report on public consultation and opinion on the draft regulation of the Minister of Health on a pilot programme for pharmacist services to patients in the field of reproductive health (after changing the title: Draft regulation of the Minister of Health on a pilot programme for pharmacist services in the field of reproductive health). [https://www.medexpress.pl/en/protection-health/pilotase-pharmaceutical-services-in-reproduction-health-care-pilot-applications-for-pharmacies/] (access: 24.06.2024).

13. Patryn R, Drozd M. Professional responsibility of the pharmacist in the Polish legal system. Acta Pol. Pharm. 2022;79(2):147-54.

14. Journal of Laws of 2024, item 662.

15. Consolidation Journal Laws of 2024, item 581.

16. Consolidation Journal Laws of 2024, item 686.

17. Consolidation Journal Laws of 2024, item 676.

18. DiPietro Mager NA, Bright DR. Promising practices and pockets of excellence: Community pharmacists supporting wellness for reproductive age women. Health Serv Res. 2022;57(6):1384-9.

19. Act of 6 November 2008 on patients’ rights and the Patients’ Rights Ombudsman (consolidated text). Journal of Laws of 2024, item 581.

20. Art. 17 sec. 2 of the Act of 6 November 2008 on Patients’ Rights and the Patients’ Rights Ombudsman (consolidated text). Journal of Laws of 2024, item 581.

21. Art. 4 sec. 2 of the law of 10 December 2020 on the profession of pharmacist (consolidated text). Journal of Laws of 2024, item 676.

22. Consolidation Journal Laws of 2024, item 146.

23. Art. 4, sec. 2, point 1, of the law of 10 December 2020 on the profession of pharmacist (consolidated text). Journal of Laws of 2024, item 676.

24. Art. 4, sec. 3, point 3 of the Law of 10 December 2020 on the profession of pharmacist (consolidated text) Journal of Laws of 2024, item 676.

25. Position of 17 April 2024 of the Presidents of the Self-governments of the Medical [https://nil.org.pl/uploaded_files/art_1713350151_medyczne-samorzady-papier-firmowy-1.pdf] (access: 25.06.2024).

26. Art. 3 sec. 4 of the Act of 6 November 2008 on Patients’ Rights and the Patients’ Rights Ombudsman (consolidated text). Journal of Laws of 2024, item 581.

27. Art. 48e, sec. 5, of the Law of 27 August 2004 on health services financed from public funds (consolidated text) Journal of Laws of 2024, item 146.

28. Journal of Laws of 2023, item 991, as amended.

29. Art. 2, sec. 1, point 10 of the Law of 15 April 2011 on medical practice (consolidated text). Journal of Laws of 2023, item 991, as amended.

30. §2 point 5 of the Regulation of the Minister of Health of 29 April 2024 on the pilot program for pharmacist services related to reproductive health. Journal of Laws of 2024, item 662).

31. §10 sec. 2 point 6 of the Regulation of the Minister of Health of 29 April 2024 on the pilot program for pharmacist services related to reproductive health (Journal of Laws of 2024, item 662.

32. §8 of the Regulation of the Minister of Health of 29 April 2024 on the pilot programme of pharmacist services in the field of reproductive health. Journal of Laws of 2024, item 662.

33. §10 sec. 3 of the Regulation of the Minister of Health of 29 April 2024 on the pilot programme of pharmacist services related to reproductive health. Journal of Laws of 2024, item 662.

34. §11 sec. 1. Journal of Laws of 2024, item 662.

35. Announcement of the Supreme Chamber of Pharmacists on the Regulation of the Minister of Health of 29 April 2024 on the pilot programme of pharmacist services related to reproductive health. Journal of Laws of 2024, item 662. [https://www.nia.org.pl/2024/04/30/komunikat-naczelnej-izby-aptekarskiej-w-sprawie-rozporzadzenia-ministra-zdrowia-z-dnia-29-kwietnia-2024-r-w-sprawie-programu-pilotazowego-w-zakresie-uslug-farmaceuty-dotyczacych-zdrowia-reprodukcje/] (access: 25.06.2024).

36. Announcement by the President of the National Health Fund on the implementation of the pilot programme in the field of pharmacist services related to reproductive health. [https://www.nfz.gov.pl/aktualnosci/aktualnosci-centrali/komunikat-prezesa-nfz-ws-realizacji-programu-pilotazowego-w-zakresie-uslug-farmaceuty-dotyczacych-zdrowia-reproduktego,8608.html] (access: 25.06.2024).

37. Document from the E-Health Centre dated 21 June 2024, reference number WWOPI.0112.114.2024.

Downloads

Published

2024-12-31